Active Ingredient History

NOW
  • Now
Chromate ion CR-51 is a radioactive chromium 51 in the form of sterile, nonpyrogenic aqueous solution of sodium chromate. It is a diagnostic radiopharmaceutical for intravenous administration. This agent provides Chromium 51 decays by electron capture and gamma emission with a physical half-life of 27.7 days. It is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss. No adverse reactions specifically attributable to Chromate ion CR-51 injection have been reported.   NCATS

More Chemistry
  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No
51cr | chromitope sodium | chromium sodium oxide (crna2o4) | rachromate | sodium chromate | sodium chromate (51cr) | sodium chromate (51cr) injection | sodium chromate cr 51 | sodium chromate cr-51 | sodium chromate(vi) | sodium chromate(vi), 51cr-labeled cpd | sodium chromate(vi), decahydrate | sodium chromate(vi), tetrahydrate | sodium radiochromate

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue